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CASE REPORT
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Summary
Introduction: Although a well-known complication in certain medical specialties, major bleed-
ing due to the interaction between oral anticoagulants and antibiotics has been rarely reported
concerning the upper aerodigestive tract. We report three cases of life-threatening bleeding
of the upper aerodigestive tract in a context of antibiotic therapy in patients treated with oral
anticoagulants.
Case series: Three male patients under coumadin anticoagulation therapy presented major
bleeding in three different contexts (epistaxis, peritonsillar abscess and postoperative course
after total laryngectomy). Surgical intervention for hemostasis was required in all cases, with
coagulation correction in two. Complications were severe anemia (2/3) and chronic heart failure
(1/3).
Discussion/conclusions: Interactions between two drugs commonly used in otolaryngology can
result in major bleeding. The goal of this article is to raise practitioners’ awareness of a
potentially fatal, although rare, complication. We also review the main preventive strategies.
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Introduction
Oral anticoagulants are widely used in the management or
prevention of thromboembolic disease. Vitamin K antago-
nists (coumadins) are the main group of oral anticoagulants
used in clinical practice in most European countries.
Their most frequent severe complication is major bleeding
[1].
Increased risk of major bleeding induced by drug interac-
tion is well established for anticoagulants and non-steroidal
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nti-inﬂammatory drugs (NSAIDs), antiplatelet drugs and
ntibiotics [1].
Antibiotic-anticoagulant interaction resulting in
ncreased bleeding risk has been clearly proven only
or quinolones and cotrimoxazole, but similar interactions
ave also been suggested for several other antibiotic
gents, especially amoxicillin (with or without clavu-
anate), cephalosporins and doxycycline [2]. The underlying
echanisms of such interaction are poorly understood
nd experimental studies in humans are sparse and based
n small series of patients [3]. A particularly relevant
bservation is reduced hepatic concentration of vitamin
resulting in modiﬁed intestinal ﬂora during antibiother-
py [4]. It should also be borne in mind that the main
harmacokinetic feature of oral anticoagulants is the
served.
1 L. Nisa et al.
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nter-individual variability of response, mainly induced by
enetic polymorphisms involving two major enzymes of the
cenocoumarol metabolic pathway: cytochrome P4502C9
CYP2C9) and vitamin K epoxide reductase [5].
ases
t must be stressed that the patients reported below:
showed international normalized ratio (INR) values prior
to antibiotherapy between two and three on repeated
measurement;
were not administered any drugs interacting with aceno-
coumarol;
were not prescribed any change in diet (Table 1).
ase 1
67-year-old man was treated for Calcinosis, Raynaud’s
yndrome, Esophageal motility disorder, Scleroderma and
elangectasia (CREST) syndrome, with acenocoumarol for
wo episodes of pulmonary embolism and extensive throm-
osis of the lower limbs. He had previously suffered
ccasional nose-bleeds.
He was managed by amoxicillin-clavulanate for an
pisode of upper respiratory tract infection, diagnosed
without further details) by his general practitioner. Three
ays later he presented to the emergency department with
evere epistaxis.
Rhinoscopy found diffuse bleeding in the posterior right
asal cavity. Nasal packing was ineffective, and surgery was
erformed for sphenopalatine artery ligature and hemosta-
is of other vessels. INR was 7.2. Postoperative course
nvolved severe anemia (hemoglobin: 50 g/L; normal range
20—160) and myocardial infarction. Bleeding recurred on
ostoperative day 2 and nasal packing was required for
days. After consultation with a cardiologist, anticoagulant
herapy was maintained: acenocoumarol was reintroduced
efore discharge at day 21.
During follow-up, the patient showed moderate chronic
eart failure.
ase 2
78-year-old man was under treatment with acenocoumarol
nd digoxin for atrial ﬁbrillation. He presented in a com-
unity clinic with a left peritonsillar abscess, for which he
as prescribed amoxicillin-clavulanate. Despite two nega-
ive needle-aspirations, the peritonsillar abscess recurred,
ausing severe odynodysphagia and respiratory discomfort.
n incision was performed under local anesthesia at day 2
f antibiotic treatment, to drain the abscess; the patient
as then switched to intravenous amoxicillin-clavulanate
or 2 days and discharged with 5 days’ antibiotics. Two
ays after discharge, he consulted again due to sudden-
nset odynophagia and left oropharyngeal hematoma in
egard of the incised abscess sac (Fig. 1). INR was 9.7, and
he patient was administered 20mg phytomenadione (syn-
hetic vitamin K1). Over the next 6 hours the hematoma
ncreased, provoking respiratory obstruction and promp-
ing urgent intubation for 7 days in the intensive care
T
t
figure 1 Computed tomography scan showing the left
ropharyngeal hematoma underlying upper airway obstruction
n patient 2 (black arrow).
nit. Acenocoumarol was replaced by standard heparin,
ntil endoscopically-controlled extubation. There were no
omplications, and acenocoumarol reintroduced before dis-
harge.
ase 3
62-year-old man had been re-admitted after salvage laryn-
ectomy, presenting with a left pharyngocutaneous ﬁstula.
e was treated with acenocoumarol for atrial ﬁbrillation
nd an episode of pulmonary embolism, and by angiotensin-
onverting enzyme inhibitor for hypertension.
Antibiotic treatment with amoxicillin-clavulanate was
tarted for periﬁstular dermo-hypodermitis. Onset of severe
leeding through the ﬁstula on the fourth day of treat-
ent was immediately identiﬁed, requiring intubation and
ransfer to surgery. The left common carotid artery was
dentiﬁed as the source of bleeding, and was ligatured
fter multiple repair attempts failed. INR was 12.3 at
he time of bleeding, compared to 2.1 the day before
nitiation of antibiotic treatment. He developed anemia
57 g/L; normal range, 120—160), and transitory sensory-
otor syndrome of the right hemi-body, which recovered
ompletely.
The patient survived without neurologic sequelae and
as discharged 3months later. Six months after discharge,
owever, he presented with esophageal varice rupture,
hich was endoscopically cauterized (the patient was not
aking antibiotics at that time).
iscussionhe essential goal of these reports is to highlight the impor-
ance of pharmacological interaction between two drugs
requently used in routine otorhinolaryngological practice.
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Table 1 Clinical and laboratory features of patients treated with oral anticoagulants and antibiotics.
Patients Clinical features INR value Management Follow-up
Context of
bleeding
Daily dose of
aceno-
coumarol
(mg)
Prior to
antibi-
otic
therapy
At time of
bleeding
Invasive
procedures
Medical
intervention
Early
complications
Late complications Time of
follow-up
Case 1 Epistaxis 3 1.9 7.2 Sphenopalatine
artery ligature
Antero-posterior
nasal packing
Vitamin K
transfusion
Severe anemia
Myocardial
infarction
Chronic heart
failure
8 months
Case 2 Peritonsillar
abscess (quinsy)
2 2.5 9.7 Orotracheal
intubation
Coagulation factors
II, VII, IX, X,
proteins S and C
Upper airway
obstruction
Full recovery 4 months
Case 3 Carotid artery
rupture
2 2.1 12.3 Carotid artery
ligature
Coagulation factors
II, VII, IX, X,
proteins S and C
Transfusion frozen
plasma
Severe anemia Transitory
sensory-motor
syndrome of the
right hemi-body
2 years
INR: international normalized ratio.
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Antibiotic prescription is common in tonsillar and per-
tonsillar infection, which are the two most frequent
iagnoses in otorhinolaryngology [6].
Epistaxis is the most frequent complication associ-
ted with anticoagulants, and spontaneous hematoma
s also frequently reported [7]. Speciﬁcally concerning
he upper aerodigestive tract, we were able to iden-
ify only one case report of pharyngolaryngeal hematoma
n an anticoagulated patient treated with clindamycin
8].
A large-scale cohort study indicated that life-threatening
leeding of the upper aerodigestive tract due to antibiotic-
nticoagulant interaction is indeed a rare occurrence [2].
t is therefore difﬁcult to formulate evidence-based recom-
endations for prevention strategies and identiﬁcation of
atients at risk [1].
In order to avoid severe bleeding as a result of oral
nticoagulant/antibiotic interaction, previously proposed
pproaches included:
preventive reduction of anticoagulant dose, with conse-
quently increased risk of thrombosis;
INR-guided dose reduction [9].
These considerations and exhaustive assessment of
ndications for antibiotherapy seem to be especially
mportant in patients under anticoagulants with a his-
ory of recurrent epistaxis, stomatorragia, hemoptysis,
ematemesis, or recent surgery of the head and neck
egion.
Severe bleeding can be life-threatening in any context,
ut in the upper aerodigestive tract there is a supple-
entary risk of respiratory obstruction which must be
ept in mind. Early intervention in such cases is manda-
ory.
onclusionespite the lack of strongly evidence-based guidelines
r the supposed rarity of the interaction reported here,
wareness on the part of otorhinolaryngologists is impor-
ant.
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